Suchergebnisse - "Foss, Francine M"

PubPharm (123)

1

The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

enthalten in: Blood advances | 2023

von Hapgood, G. | Civallero, M. | Stepanishyna, Y. | +17

2

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Chavez, J. | Foss, F. | William, B. | +23

3

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma

enthalten in: Blood advances | 2023

von Potnis, K. | Di, M. | Isufi, I. | +5

CommentIn: Blood Adv. 2023 Jun 13;7(11):2494-2495. - PMID 36661331

4

Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations

enthalten in: Blood advances | 2023

von Ren, J. | Qu, R. | Rahman, N. | +16

5

Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas : a meta-analysis

enthalten in: Blood advances | 2022

von Shafagati, N. | Koh, M. | Boussi, L. | +6

6

Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas

enthalten in: Blood advances | 2022

von Koh, M. | Merrill, M. | Koh, M. | +20

ErratumIn: Blood Adv. 2022 Aug 9;6(15):4436. - PMID 35913750

7

Uncovering the Potential of Phosphatidylinositol 3-Kinase Inhibitors in Cutaneous T-Cell Lymphoma : Insights from High-Throughput In Vitro Screenings

enthalten in: The Journal of investigative dermatology | 2022

von King, A. | Mirza, F. | Lewis, J. | +5

CommentOn: J Invest Dermatol. 2021 Feb;141(2):364-373. - PMID 32603749

8

Necrotic papulonodules on the legs

enthalten in: JAAD case reports | 2021

von Zhou, A. | Damsky, W. | Girardi, M. | +2

9

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma

enthalten in: Experimental hematology & oncology | 2021

von Johnston, P. | Cashen, A. | Nikolinakos, P. | +8

10

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma

enthalten in: Experimental hematology & oncology | 2021

von Johnston, P. | Cashen, A. | Nikolinakos, P. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]